ArticleTransplantation direct2023

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.

Michele Malagola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.